FDA Worried Your Blood Transfusion Might Come With Malaria
Published Date: 1/16/2025
Notice
Summary
The FDA is rolling out new draft rules to help blood banks better spot and stop malaria from sneaking into blood donations. Blood centers will start using special tests to check donors who might have malaria, making transfusions safer for everyone. If you’re involved in blood collection, get ready to share your thoughts by March 17, 2025, before these changes become official!
Analyzed Economic Effects
3 provisions identified: 2 benefits, 1 costs, 0 mixed.
Selective NAT Testing for At‑Risk Donors
The FDA’s draft guidance recommends that blood establishments selectively test donations from donors at risk for malaria using an FDA-licensed donor screening nucleic acid test (NAT) for Plasmodium species. This recommendation applies to the collection of Whole Blood and blood components and is intended to replace the December 2022 recommendations when finalized.
Reduced Risk of Transfusion‑Transmitted Malaria
If blood donations from donors at risk for malaria are selectively tested with an FDA-licensed donor screening NAT for Plasmodium species, transfusion recipients should face a lower risk of transfusion-transmitted malaria (TTM). The draft guidance is intended to supersede the December 2022 recommendations if finalized.
Source Plasma Collections Are Exempt
The draft guidance does not recommend screening Source Plasma donors for malaria risk factors because Source Plasma undergoes manufacturing steps that remove or inactivate pathogens and licensed plasma derivatives from Source Plasma have not transmitted malaria. The guidance’s recommendations apply to Whole Blood and blood components, except Source Plasma.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Related Federal Register Documents
2026-13436 — Polyvinyl Alcohol From China and Japan; Scheduling of Expedited Five-Year Reviews
The U.S. International Trade Commission is speeding up its review to decide if special taxes on polyvinyl alcohol from China and Japan should continue. This affects companies that make or sell this material in the U.S. The review started on June 5, 2026, and could impact prices and trade rules soon.
2026-13431 — Submission for Review: Report of Medical Examination of Person Electing Survivor Benefits, OPM 1530, 3206-0162
If you’re applying for survivor benefits from the federal government, you might need to fill out a medical exam report form. The Office of Personnel Management is asking for public feedback on this form to make sure it’s clear and not too much work. Comments are open until August 3, 2026, so now’s the time to speak up if you have ideas or concerns!
2026-13480 — Government Owned Invention Available for License: A Conserved Viral Peptide for Use in Cancer Immunotherapy
The National Cancer Institute has created a special viral peptide that could help prevent and treat a serious liver cancer called HCC. This new discovery might lead to a vaccine or therapy that boosts the immune system to fight cancer better. Researchers and companies interested in developing this treatment can now license the technology, opening doors for faster progress and potential health benefits worldwide.
2026-13453 — Privacy Act of 1974; System of Records
The Department of Veterans Affairs is updating its system that tracks debts from VA benefits like education, compensation, and loans. If you owe money to the VA, this change affects how your info is stored and used. You have 30 days to share your thoughts before the update goes live, but no extra costs or delays are expected.
2026-13466 — Notice of Renewal of the MCC Advisory Council and Call for Nominations
The Millennium Challenge Corporation (MCC) has renewed its Advisory Council for 2026-2028 and is looking for new members from private companies with skills in areas like technology, finance, and infrastructure. This group helps MCC fight poverty by giving smart advice on projects in developing countries. If you want to join, send your nomination by August 7, 2026, and get ready to meet up to four times a year, either in person or online.
2026-13432 — Submission for Review: Initial Certification of Full-Time School Attendance, RI 25-41, 3206-0099
The Office of Personnel Management is asking for public feedback on a form that proves kids are attending school full-time, which helps determine survivor benefits. This review affects families receiving these benefits and aims to keep the form clear and easy to use. Comments are open until August 3, 2026, so now’s the time to speak up and help shape the process!
Previous / Next Documents
Previous: 2025-01027 — Proposal to Refuse to Approve a New Drug Application for TRADIPITANT; Opportunity for a Hearing
The FDA is thinking about saying no to Vanda Pharmaceuticals' new drug, TRADIPITANT, in its current form. Vanda can ask for a hearing to explain why the drug should be approved. If you want to speak up or support the hearing, you’ve got until mid-February and mid-March 2025 to send in your requests and info.
Next: 2025-01029 — United States Classes, Standards, and Grades for Poultry
The USDA is updating the rules that decide how poultry is classified and graded to keep up with new farming methods and what shoppers want. This affects poultry producers, sellers, and buyers who rely on clear quality standards. You can share your thoughts by March 17, 2025, so get ready to weigh in and help shape the future of poultry labeling!